Vinod P Balachandran

Sloan-Kettering Inst Can Research

$5,168,008

Attributed

$8,122,469

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.9M · FY2017–25

$2M$1.5M$1M$500K$0

'17

'18

'19

'20

'21

'22

'23

'24

'25

Funding mix

By agency

NIH$8,122,469 · 3

By mechanism

U01$3,080,547 · 1

R01$2,828,375 · 1

P50$2,213,547 · 1

Top collaborators

Taha Merghoub4 shared
Steven D Leach3 shared

Most similar at Sloan-Kettering Inst Can Research

Same institution · by research overlap

Timothy An-Thy Chan$21,076,830
Tobias M Hohl$16,351,909
Alan M Hanash$10,698,469
Andrew Y Koh$4,547,928
Ping Chi$18,562,542

Others in their field

Other Emerging Leaders on “T-Lymphocyte”

Gautam (george) Mitra · Leidos Biomedical Research, Inc.$53,523,213
Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$20,250,477
Crystal Mackall · Children'S Hosp Of Philadelphia$16,367,876
Wilton B Williams · Duke University$16,226,847
Gary Fanger · Rise Therapeutics, Llc$15,372,982
Aaron Esser-Kahn · University Of Chicago$13,378,548

Research focus

T-LymphocyteImmunotherapyMalignant Neoplasm Of PancreasMolecularMalignant NeoplasmsResponseTissuesTumorImmunityClinical TrialsLymphoid CellInterleukinsChemokineBiologyCellsLymphocytePancreatic Ductal AdenocarcinomaImmune CheckpointOrganoidsPathway InteractionsDendritic CellsCd8-Positive T-LymphocytesMouse ModelCytokine